Sigrima Pertuzumab 420 mg Injection
Sigrima Pertuzumab 420 mg Injection is a targeted anti-cancer medication used primarily in the treatment of HER2-positive breast cancer. It contains Pertuzumab, a monoclonal antibody that works by specifically targeting the HER2 receptors on cancer cells. By blocking these receptors, it prevents cancer cell growth and division, helping to slow or stop the progression of the disease.
Pertuzumab is often used in combination with other chemotherapy drugs and targeted therapies such as Trastuzumab to enhance treatment effectiveness. This combination therapy has significantly improved survival outcomes in patients with HER2-positive breast cancer.
📞 Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com
Composition and Content
Active Ingredient: Pertuzumab
Strength: 420 mg / 14 mL vial
Form: Solution for intravenous infusion
Drug Class: Monoclonal antibody (HER2 inhibitor)
How to Use
Administered as an intravenous (IV) infusion under medical supervision.
Usually given in a hospital or oncology clinic.
Not for self-administration.
Often used in combination with chemotherapy and HER2-targeted therapies.
Dosage
Initial Dose: 840 mg IV infusion
Maintenance Dose: 420 mg every 3 weeks
Duration and regimen depend on patient condition and treatment response.
Always follow the oncologist’s prescription.
Uses
Sigrima Pertuzumab 420 mg Injection is used for:
HER2-positive metastatic breast cancer
Early-stage HER2-positive breast cancer (neoadjuvant/adjuvant therapy)
Recurrent breast cancer
Treatments (Combination Therapy)
Commonly used with:
Trastuzumab
Chemotherapy agents like docetaxel
Targeted therapy regimens for advanced cancer care
Advantages
Specifically targets cancer cells (precision therapy)
Improves survival rates in HER2-positive patients
Works synergistically with other therapies
Reduces tumor growth and spread
Well-studied and clinically proven treatment
Storage Conditions
Store in a refrigerator at 2°C to 8°C
Do not freeze
Protect from light
Keep in original packaging
Use immediately after dilution (as per medical guidelines)
Alternative Indian Brands
Some alternative brands containing Pertuzumab include:
Perjeta (by Roche)
Biosimilar versions (availability may vary in India depending on approval and supplier)
🌐Buy Sigrima Pertuzumab 420 mg Injection Online
Purchase Today – Sigrima Pertuzumab 420 mg Injection | GlobMedIndia
Looking to buy Sigrima Pertuzumab 420 mg Injection online at the best price? GlobMedIndia – The Medicine Exporter offers safe, reliable, and fast global delivery of anti-cancer medicines to patients and healthcare providers worldwide.
We specialize in supplying high-quality oncology drugs including Pertuzumab for the treatment of HER2-positive breast cancer.
🌍 Global Supply & Delivery Locations
We deliver across:
USA: Cambridge, New York, Los Angeles
UK: London, Manchester
UAE: Dubai, Abu Dhabi
Australia: Sydney, Melbourne
Europe: Romania, Ukraine, Germany, France
Asia: China, Japan, South Korea, Thailand, Vietnam, Indonesia
Africa: Morocco, Ethiopia, South Africa
South America: Chile, Peru
Middle East & Southeast Asia
Why Choose GlobMedIndia?
Trusted exporter of oncology medicines
Affordable pricing & genuine products
Temperature-controlled shipping
Doorstep delivery worldwide
24/7 customer support
Buy Sigrima Pertuzumab 420 mg Injection online
Pertuzumab injection supplier India
HER2 breast cancer treatment drugs
Purchase Perjeta biosimilar online
Anti-cancer medicine exporter India
Pertuzumab price USA UK UAE
Oncology medicine supplier worldwide
Buy HER2 targeted therapy online
GlobMedIndia cancer medicine export
Affordable breast cancer injection worldwide
Conclusion
Sigrima Pertuzumab 420 mg Injection is a life-saving targeted therapy that has transformed the treatment of HER2-positive breast cancer. Always consult an oncologist before starting treatment and ensure proper medical supervision during administration.
